文献速递腹部介入MR

基于治疗前对比增强MRI栖息地分析和Crossformer模型预测肝细胞癌经动脉化疗栓塞联合系统治疗方案的疗效反应

Prediction of therapeutic response to transarterial chemoembolization plus systemic therapy regimen in hepatocellular carcinoma using pretreatment contrast-enhanced MRI based habitat analysis and Crossformer model.
PubMed 文献 · Abdom Radiol (NY) · 2024-11-26

本研究自两家机构纳入2020年9月至2024年1月接受TACE联合分子靶向治疗及抗PD-(L)1治疗的102例HCC患者,利用多期CE-MRI栖息地图像构建ExtraTrees栖息地模型和基于Transformer聚合的Crossformer深度学习模型,在机构B验证中Crossformer模型AUC为0.762、栖息地模型AUC为0.721,提示基于CE-MRI的栖息地模型和深度学习模型能够无创预测TACE联合系统治疗的疗效。

要点

  • 治疗前多期CE-MRI可无创预测HCC对TACE联合系统治疗的疗效反应。
  • Crossformer模型验证队列AUC为0.762,栖息地模型验证队列AUC为0.721。
  • K-means聚类将瘤内体素分为三个亚区,用于提取栖息地影像组学特征。

核心结论

  • 基于CE-MRI的栖息地模型和深度学习模型能够无创预测HCC患者接受TACE联合系统治疗的疗效,这对精准治疗和患者结局至关重要。

研究设计与样本

  • 研究纳入两家机构(A机构n=63、B机构n=39)共102例接受TACE联合系统治疗的HCC患者,时间范围为2020年9月至2024年1月;使用多期CE-MRI序列勾画病灶3D感兴趣体积,以K-means聚类按图像信号强度值将瘤内体素分为三个亚组;在A机构数据上提取瘤内栖息地影像组学特征后以ExtraTrees分类器构建栖息地模型,并以多通道数据训练Crossformer模型和ResNet50模型、构建基于Transformer聚合的深度学习模型,所有模型在B机构验证。

诊断标准与关键数值

  • Crossformer模型训练队列AUC为0.869,验证队列AUC为0.762。
  • 栖息地模型训练队列AUC为0.877,验证队列AUC为0.721。

临床应用与阅片要点

  • 作者认为基于CE-MRI的栖息地模型和深度学习模型能够无创预测HCC患者TACE联合系统治疗的疗效,对精准治疗和患者结局至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To develop habitat and deep learning (DL) models from multi-phase contrast-enhanced magnetic resonance imaging (CE-MRI) habitat images categorized using the K-means clustering algorithm. Additionally, we aim to assess the predictive value of identified regions for early evaluation of the responsiveness of hepatocellular carcinoma (HCC) patients to treatment with transarterial chemoembolization (TACE) plus molecular targeted therapies (MTT) and anti-PD-(L)1.

METHODS: A total of 102 patients with HCC from two institutions (A, n = 63 and B, n = 39) who received TACE plus systemic therapy were enrolled from September 2020 to January 2024. Multiple CE-MRI sequences were used to outline 3D volumes of interest (VOI) of the lesion. Subsequently, K-means clustering was applied to categorize intratumoral voxels into three distinct subgroups, based on signal intensity values of images. Using data from institution A, the habitat model was built with the ExtraTrees classifier after extracting radiomics features from intratumoral habitats. Similarly, the Crossformer model and ResNet50 model were trained on multi-channel data in institution A, and a DL model with Transformer-based aggregation was constructed to predict the response. Finally, all models underwent validation at institution B.

RESULTS: The Crossformer model and the habitat model both showed high area under the receiver operating characteristic curves (AUCs) of 0.869 and 0.877 (training cohort). In validation, AUC was 0.762 for the Crossformer model and 0.721 for the habitat model.

CONCLUSION: The habitat model and DL model based on CE-MRI possesses the capability to non-invasively predict the efficacy of TACE plus systemic therapy in HCC patients, which is critical for precision treatment and patient outcomes.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Zhu Y, Liu T, Chen J, et al. Prediction of therapeutic response to transarterial chemoembolization plus systemic therapy regimen in hepatocellular carcinoma using pretreatment contrast-enhanced MRI based habitat analysis and Crossformer model. Abdom Radiol (NY). 2024. PMID: 39586897. doi:10.1007/s00261-024-04709-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。